Literature DB >> 2337788

The ventral pallidum plays a role in mediating cocaine and heroin self-administration in the rat.

C B Hubner1, G F Koob.   

Abstract

The hypothesis that the ventral pallidum is an important site mediating psychomotor stimulant and opiate reinforcement was tested in rats trained to self-administer i.v. cocaine or heroin. Ibotenic acid lesions of the ventral pallidum produced significant decreases in cocaine and heroin self-administration behavior maintained on a fixed-ratio 5 schedule of reinforcement, suggesting an attenuation of the reinforcing value of cocaine and heroin. On a progressive-ratio schedule, ventral pallidal lesions produced significant decreases in the highest ratio obtained in rats self-administering cocaine. Similar results were observed with heroin in a progressive-ratio procedure modified to produce higher levels of responding; lesions of the ventral pallidum produced a significant decrease in the highest ratio obtained. Further, the i.v. co-administration of naloxone and heroin produced a decrease in progressive-ratio responding relative to heroin alone using the modified progressive-ratio schedule. These results suggest that the ventral pallidum is an important site mediating the reinforcing effects of cocaine and heroin and that the nucleus accumbens-ventral pallidum circuit may be a common pathway for both stimulant and opiate reinforcement.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2337788     DOI: 10.1016/0006-8993(90)91112-t

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  62 in total

Review 1.  Functional genomics and psychiatric illness.

Authors:  Wendy Hasenkamp; Scott E Hemby
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

2.  Self-administration of heroin in rats: effects of low-level lead exposure during gestation and lactation.

Authors:  Angelica Rocha; Rodrigo Valles; Aaron L Cardon; Gerald R Bratton; Jack R Nation
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

3.  Slow phasic and tonic activity of ventral pallidal neurons during cocaine self-administration.

Authors:  David H Root; Anthony T Fabbricatore; Anthony P Pawlak; David J Barker; Sisi Ma; Mark O West
Journal:  Synapse       Date:  2011-11-03       Impact factor: 2.562

4.  Relative contributions and mapping of ventral tegmental area dopamine and GABA neurons by projection target in the rat.

Authors:  Jocelyn M Breton; Annabelle R Charbit; Benjamin J Snyder; Peter T K Fong; Elayne V Dias; Patricia Himmels; Hagar Lock; Elyssa B Margolis
Journal:  J Comp Neurol       Date:  2018-12-11       Impact factor: 3.215

Review 5.  Animal models of drug craving.

Authors:  A Markou; F Weiss; L H Gold; S B Caine; G Schulteis; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Heroin self-administration in rats under a progressive ratio schedule of reinforcement.

Authors:  D C Roberts; S A Bennett
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 7.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17

8.  Transsynaptic induction of c-fos in basal forebrain, diencephalic and midbrain neurons following AMPA-induced activation of the dorsal and ventral striatum.

Authors:  K J Page; B J Everitt
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

9.  Cocaine dysregulates opioid gating of GABA neurotransmission in the ventral pallidum.

Authors:  Yonatan M Kupchik; Michael D Scofield; Kenner C Rice; Kejun Cheng; Bernard P Roques; Peter W Kalivas
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

10.  A new progressive ratio schedule for support of morphine self-administration in opiate dependent rats.

Authors:  Kenneth Grasing; Ning Li; Shaunteng He; Christopher Parrish; John Delich; John Glowa
Journal:  Psychopharmacology (Berl)       Date:  2003-05-06       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.